There are two Otsuka pharmaceutical industry companies in the U.S.: Otsuka America Pharmaceutical, Inc. (OAPI) successfully commercializes Otsuka-discovered and in-licensed products in North America. Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) clinically develops and registers innovative healthcare products on a global basis.
Looking for a particular Otsuka Pharmaceutical Companies (U.S.) employee's phone or email?
The Otsuka Pharmaceutical Companies (U.S.) annual revenue was $675.1 million in 2026.
Tarek Rabah is the President and CEO of Otsuka Pharmaceutical Companies (U.S.).
2,839 people are employed at Otsuka Pharmaceutical Companies (U.S.).
Otsuka Pharmaceutical Companies (U.S.) is based in Princeton, New Jersey.
The NAICS codes for Otsuka Pharmaceutical Companies (U.S.) are [3254, 32, 32541, 325].
The SIC codes for Otsuka Pharmaceutical Companies (U.S.) are [283, 28].